Efficacy and Safety Results of Guselkumab in Patients with Active Psoriatic Arthritis over 56 Weeks from a Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study

被引：0

作者：

Deodhar, Atul A. ^{[1
]}

Gottlieb, Alice B. ^{[2
]}

Boehncke, Wolf-Henning ^{[3
,4
]}

Dong, Bin ^{[5
]}

Wang, Yuhua ^{[5
]}

Zhuang, Yanli ^{[5
]}

Barchuk, William ^{[6
]}

Xu, Xie L. ^{[6
]}

Hsia, Elizabeth ^{[5
]}

机构：

[1] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis OP09, Portland, OR 97201 USA

[2] New York Med Coll, Dept Dermatol, Valhalla, NY 10595 USA

[3] Geneva Univ Hosp, Geneva, Switzerland

[4] Univ Geneva, Geneva, Switzerland

[5] Janssen Res & Dev LLC, Spring House, PA USA

[6] Janssen Res & Dev LLC, San Diego, CA USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2878

引用

页数：4

共 50 条

[41] Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
Mease, Philip J.
Rahman, Proton
Gottlieb, Alice B.
Kollmeier, Alexa P.
Hsia, Elizabeth C.
Xu, Xie L.
Sheng, Shihong
Agarwal, Prasheen
Zhou, Bei
Zhuang, Yanli
van der Heijde, Desiree
McInnes, Iain B.
LANCET, 2020, 395 (10230): : 1126 - 1136
[42] Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
McInnes, Iain B.
Kavanaugh, Arthur
Gottlieb, Alice B.
Puig, Lluis
Rahman, Proton
Ritchlin, Christopher
Brodmerkel, Carrie
Li, Shu
Wang, Yuhua
Mendelsohn, Alan M.
Doyle, Mittie K.
LANCET, 2013, 382 (9894): : 780 - 789
[43] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 1 Year Results of the Phase 3, Multicentre, Double-Blind, Placebo-Controlled PSUMMIT 1 Trial
Lunzer, R.
JOURNAL FUR MINERALSTOFFWECHSEL, 2013, 20 (04): : 175 - 176
[44] Alefacept in combination with methotrexate for the treatment of psoriatic arthritis - Results of a randomized, double-blind, placebo-controlled study
Mease, Philip J.
Gladman, Dafna D.
Keystone, Edward C.
ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1638 - 1645
[45] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
Goodman, A. D.
Rossman, H.
Bar-Or, A.
Miller, A.
Miller, D. H.
Schmierer, K.
Lublin, F.
Khan, O.
Bormann, N. M.
Yang, M.
Panzara, M. A.
Sandrock, A. W.
NEUROLOGY, 2009, 72 (09) : 806 - 812
[46] A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF AURANOFIN IN PATIENTS WITH PSORIATIC-ARTHRITIS
CARETTE, S
CALIN, A
MCCAFFERTY, JP
WALLIN, BA
ARTHRITIS AND RHEUMATISM, 1989, 32 (02): : 158 - 165
[47] Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study
Mease, Philip J.
Chohan, Saima
Fructuoso, Ferran J. Garcia
Luggen, Michael E.
Rahman, Proton
Raychaudhuri, Siba P.
Chou, Richard C.
Mendelsohn, Alan M.
Rozzo, Stephen J.
Gottlieb, Alice
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (09) : 1147 - 1157
[48] Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylitis and Peripheral Joint Involvement: Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study.
Kavanaugh, Arthur
Puig Sanz, Lluis
Gottlieb, Alice B.
Ritchlin, Christopher T.
You, Yin
Wang, Yuhua
Mendelsohn, Alan M.
Song, Michael
Rahman, Proton
McInnes, Iain B.
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S234 - S234
[49] Efficacy and safety of anamorelin HCl in NSCLC patients: Results from a randomized, double-blind, placebo-controlled, multicenter phase II study
Temel, J.
Bondarde, S.
Jain, M.
Allen, S.
Mann, W.
EUROPEAN JOURNAL OF CANCER, 2013, 49 : S269 - S270
[50] Safety of tildrakizumab in psoriatic arthritis: An interim analysis from a randomized, double-blind, placebo-controlled phase 2b trial
Ritchlin, Christopher T.
Strand, Vibeke
Ballerini, Rocco
Chou, Richard
Rozzo, Stephen J.
Mendelsohn, Alan M.
Kavanaugh, Arthur
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB166 - AB166

← 1 2 3 4 5 →